Bone Biologics (BBLG) Selling, General & Administrative (2014 - 2026)
Powered by 
Analysis
Bone Biologics (BBLG) Selling, General & Administrative (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - | 499,359.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 499,359.00 |
| Dec 31, 2025 | 475,908.00 |
| Sep 30, 2025 | 527,466.00 |
| Jun 30, 2025 | 556,467.00 |
| Mar 31, 2025 | 614,910.00 |
| Dec 31, 2024 | 450,367.00 |
| Sep 30, 2024 | 521,274.00 |
| Jun 30, 2024 | 459,223.00 |
| Mar 31, 2024 | 657,911.00 |
| Dec 31, 2023 | 712,931.00 |
| Sep 30, 2023 | 506,040.00 |
| Jun 30, 2023 | 744,617.00 |
| Mar 31, 2023 | 556,892.00 |
| Dec 31, 2022 | 531,205.00 |
| Sep 30, 2022 | 449,867.00 |
| Jun 30, 2022 | 451,704.00 |
| Mar 31, 2022 | 653,099.00 |
| Dec 31, 2021 | 425,954.00 |
| Sep 30, 2021 | 229,789.00 |
| Jun 30, 2021 | 229,865.00 |